Article info
PDFEditorial commentary
Sequencing of and escalation paradigms for MS therapies: time for a rethink?
- Correspondence to Professor Bruce V Taylor, University of Tasmania Menzies Research Institute, Hobart, TAS 7001, Australia; bruce.taylor{at}utas.edu.au
Citation
Sequencing of and escalation paradigms for MS therapies: time for a rethink?
Publication history
- Received April 23, 2021
- Accepted April 29, 2021
- First published June 8, 2021.
Online issue publication
January 10, 2022
Article Versions
- Previous version (8 January 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.